Evidence-based guides on GLP-1 medicines and weight management
A practical guide for Indian patients on how to find a qualified endocrinologist or diabetologist familiar with semaglutide and tirzepatide, what a good first consultation looks like, and how to seek a second opinion.
Read more→A complete guide to HbA1c targets for Indian GLP-1 users — what to aim for, how much reduction to expect, how often to test, and what to do if numbers are not improving.
Read more→When a family member is on GLP-1 medications, the whole household is affected. This practical guide for Indian spouses, parents, and adult children explains how to support without pressure — at the table, in the kitchen, and through emotional complexity.
Read more→Sleep is deeply connected to GLP-1 therapy outcomes — poor sleep raises hunger hormones, stalls weight loss, and worsens insulin resistance. This guide explains the sleep-GLP-1 relationship and practical steps for Indian patients.
Read more→How India's 10–15 million night shift workers in IT, BPO, healthcare, and manufacturing can optimise GLP-1 injection timing, canteen meal choices, and side effect management on a reversed circadian schedule.
Read more→Homemakers face unique GLP-1 challenges: constant kitchen access, cooking and tasting all day, eating after everyone else, limited exercise autonomy. Here is a practical daily routine built specifically for Indian women managing GLP-1 medications at home.
Read more→Most Indian GLP-1 users are already on multiple medications for diabetes, blood pressure, and cholesterol. This guide covers the three key risks — hypoglycaemia, levothyroxine absorption, and compounding blood pressure reduction — with practical medication schedules and doctor communication tips.
Read more→Olanzapine, clozapine, and quetiapine cause 6–15 kg of weight gain in the first year. The OVERCOME trial shows semaglutide produces significant weight loss in schizophrenia patients without worsening psychiatric symptoms. Here is the complete India guide.
Read more→A practical guide for Indian patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) who are considering or currently using GLP-1 medications — covering dosing, energy management, post-exertional malaise, and when to see your doctor.
Read more→